Suven Life Sciences Limited Share Price and Company Fundamentals

-1.800 (-2.559%)
52 week
60.8 - 124.45

Last traded: Yesterday at 9:59 AM

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. It engages in drug discovery and development of new chemical entities (NCE) in central nervous system therapies. The company's product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911, a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. It is also develops SUVN-D4010, a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Mailing address# 8-2-334, SDE Serene Chambers 6th Floor Avenue - 7 Road No. 5, Banjara Hills Hyderabad 500034 India
Phone / Fax91 40 2354 1142 / 91 40 2354 1152


Dividend yield


Dividend amount


Payout ratio


Suven Life Sciences Limited paid ₹1.00 dividend and the ex-dividend date was 14 Feb 2019.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SUVEN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

SUVEN's forward dividend amount is ₹ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Suven Life Sciences Limited.

NameTitleAgeTotal Pay
Mr. Venkateswarlu Jasti M.Pharm. M.S.Exec. Chairman & CEO72
Ms. Sudharani Jasti B.Sc.Whole-Time Director6721.53M
Mr. M. Mohan KumarChief Financial Officer
Mr. Shrenik SoniCompany Sec. & Compliance Officer
Ms. Kalyani JastiPres of US Operations42

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Suven Life Sciences Limited is and its enterprise value is .

The SUVEN's stocks Beta value is 2.03 making it 103% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Suven Life Sciences Limited (NSE:SUVEN) Frequently Asked Questions

1. What is Suven Life Sciences Limited's Stock Symbol?

Suven Life Sciences Limited trades on NSE under the ticker symbol "SUVEN".

2. What is Suven Life Sciences Limited's stock price today?

One share of SUVEN stock can currently be purchased for approximately ₹68.55.

3. How can I contact Suven Life Sciences Limited?

Suven Life Sciences Limited's mailing address is # 8-2-334, SDE Serene Chambers 6th Floor Avenue - 7 Road No. 5, Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 2354 1142.

4. What is Suven Life Sciences Limited's official website?

The official website of Suven Life Sciences Limited is